Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ACT1VATE: Addressing Emotional Distress to Improve Outcomes Among Diverse Adults With Type 1 Diabetes

NCT04933851 is registered in ClinicalTrials.gov with Scripps Whittier Diabetes Institute as lead sponsor.

NCT NCT04933851
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04933851 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ACT1VATE: Addressing Emotional Distress to Improve Outcomes Among Diverse Adults With Type 1 Diabetes
Lead sponsor
Scripps Whittier Diabetes Institute
Phase
Phase 2
Overall status
Recruiting
Start date
October 25, 2021
Completion date
March 31, 2027
Enrollment
250 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 1 diabetes